Literature DB >> 27101016

Managing Patients with Cutaneous B-Cell and T-Cell Lymphomas Other Than Mycosis Fungoides.

Meenal Kheterpal1,2, Neha Mehta-Shah3,4, Pooja Virmani1,5, Patricia L Myskowski1,5, Alison Moskowitz3,6, Steven M Horwitz7,8.   

Abstract

Cutaneous lymphomas (CL) are a heterogeneous group of neoplasms characterized with clinical and histopathological variation, as well as overlap with benign dermatoses. Diagnosis and treatment of CLs is challenging and often requires a multidisciplinary approach. However, prognostic knowledge of these conditions and awareness of treatment options can help optimize appropriate use of available regimens, thereby improving care for patients. Here, we review the most recent literature and outline treatment themes for managing patients with cutaneous B-cell and T-cell lymphomas other than mycosis fungoides.

Entities:  

Keywords:  Cutaneous T-cell lymphoma; Multidisciplinary approach; Non-mycosis fungoides; Primary cutaneous B-cell lymphoma; Skin-directed treatment; Systemic treatment

Mesh：

Year:  2016        PMID： 27101016      PMCID： PMC5611851          DOI： 10.1007/s11899-016-0322-5

Source DB:  PubMed          Journal:  Curr Hematol Malig Rep        ISSN： 1558-8211            Impact factor:   3.952


  105 in total

1.  Primary cutaneous B-cell lymphoma.

Authors:  Melissa A Bogle; Christy C Riddle; Emily M Triana; Dan Jones; Madeleine Duvic
Journal:  J Am Acad Dermatol       Date:  2005-09       Impact factor: 11.527

2.  Evaluation of B-cell clonality using the BIOMED-2 PCR method effectively distinguishes cutaneous B-cell lymphoma from benign lymphoid infiltrates.

Authors:  Anjali V Morales; Daniel A Arber; Katie Seo; Sabine Kohler; Youn H Kim; Uma N Sundram
Journal:  Am J Dermatopathol       Date:  2008-10       Impact factor: 1.533

Review 3.  Primary cutaneous small- to medium-sized CD4+ pleomorphic T-cell lymphoma: a retrospective case series and review of the provisional cutaneous lymphoma category.

Authors:  Victoria L Williams; Carlos A Torres-Cabala; Madeleine Duvic
Journal:  Am J Clin Dermatol       Date:  2011-12-01       Impact factor: 7.403

4.  Primary cutaneous B-cell lymphoma and Borrelia burgdorferi infection in patients from the Highlands of Scotland.

Authors:  J R Goodlad; M M Davidson; K Hollowood; C Ling; C MacKenzie; I Christie; P J Batstone; D O Ho-Yen
Journal:  Am J Surg Pathol       Date:  2000-09       Impact factor: 6.394

Review 5.  EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma.

Authors:  Werner Kempf; Katrin Pfaltz; Maarten H Vermeer; Antonio Cozzio; Pablo L Ortiz-Romero; Martine Bagot; Elise Olsen; Youn H Kim; Reinhard Dummer; Nicola Pimpinelli; Sean Whittaker; Emmilia Hodak; Lorenzo Cerroni; Emilio Berti; Steve Horwitz; H Miles Prince; Joan Guitart; Teresa Estrach; José A Sanches; Madeleine Duvic; Annamari Ranki; Brigitte Dreno; Sonja Ostheeren-Michaelis; Robert Knobler; Gary Wood; Rein Willemze
Journal:  Blood       Date:  2011-08-12       Impact factor: 22.113

6.  TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the Cutaneous Lymphoma Task Force of the European Organization of Research and Treatment of Cancer (EORTC).

Authors:  Youn H Kim; Rein Willemze; Nicola Pimpinelli; Sean Whittaker; Elise A Olsen; Annamari Ranki; Reinhard Dummer; Richard T Hoppe
Journal:  Blood       Date:  2007-03-05       Impact factor: 22.113

7.  Primary cutaneous B cell lymphoma: outcomes and treatment.

Authors:  K C Wong; P A Weller
Journal:  Australas J Dermatol       Date:  1998-11       Impact factor: 2.875

8.  Bcl-2 protein expression is the strongest independent prognostic factor of survival in primary cutaneous large B-cell lymphomas.

Authors:  Florent Grange; Tony Petrella; Marie Beylot-Barry; Pascal Joly; Michel D'Incan; Michele Delaunay; Laurent Machet; Marie-Francoise Avril; Sophie Dalac; Philippe Bernard; Agnes Carlotti; Eric Esteve; Beatrice Vergier; Pierre Dechelotte; Elisabeth Cassagnau; Philippe Courville; Philippe Saiag; Liliane Laroche; Martine Bagot; Janine Wechsler
Journal:  Blood       Date:  2004-01-15       Impact factor: 22.113

9.  [Two cases of subcutaneous panniculitis-like T-cell lymphoma (CD4- CD8+ CD56-)].

Authors:  G Springinsfeld; J-C Guillaume; P Boeckler; M-C Tortel; B Cribier
Journal:  Ann Dermatol Venereol       Date:  2008-12-06       Impact factor: 0.777

10.  PUVA-induced lymphomatoid papulosis in a patient with mycosis fungoides.

Authors:  P Wolf; L Cerroni; J Smolle; H Kerl
Journal:  J Am Acad Dermatol       Date:  1991-08       Impact factor: 11.527
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.